Jaquecas

Volver al artículo.

Referencias para el artículo

  1. Wilkinson CF Jr. Recurrent migrainoid headaches associated with spontaneous hypoglycemia. Am J Med Sci 1949;218:209–12.
  2. Dexter JD, Roberts J, Byer JA. The five hour glucose tolerance test and effect of low sucrose diet in migraine. Headache 1978;18:91–4.
  3. Grant EC. Food allergies and migraine. Lancet 1979;i:966–9.
  4. Monro J, Brostoff J, Carini C, Zilkha K. Food allergy in migraine. Lancet 1980;ii:1–4.
  5. Egger J, Carter CM, Wilson J, et al. Is migraine food allergy? A double-blind controlled trial of oligoantigenic diet treatment. Lancet 1983;ii:865–9.
  6. Hughs EC, Gott PS, Weinstein RC, Binggeli R. Migraine: a diagnostic test for etiology of food sensitivity by a nutritionally supported fast and confirmed by long-term report. Ann Allergy 1985;55:28–32.
  7. Egger J, Carter CM, Soothill JF, Wilson J. Oligoantigenic diet treatment of children with epilepsy and migraine. J Pediatr 1989;114:51–8.
  8. Brainard JB. Angiotensin and aldosterone elevation in salt-induced migraine. Headache 1981;21:222–6.
  9. Ratner D, Shoshani E, Dubnov B. Milk protein-free diet for nonseasonal asthma and migraine in lactase-deficient patients. Isr J Med Sci 1983;19:806–9.
  10. Hanington E. Preliminary report on tyramine headache. Br Med J 1967;2:550–1.
  11. Smith I, Kellow AH, Hanington E. A clinical and biochemical correlation between tyramine and migraine headache. Headache 1970;10:43–51.
  12. Perkine JE, Hartje J. Diet and migraine: a review of the literature. J Am Diet Assoc 1983;83:459–63.
  13. Koehler SM, Glaros A. The effect of aspartame on migraine headache. Headache 1988;28:10–3.
  14. Lipton RB, Newman LC, Solomon S. Aspartame and headache. N Engl J Med 1988;318:1200–1.
  15. Hasselmark L, Malmgren R, Hannerz J. Effect of a carbohydrate-rich diet, low in protein-tryptophan, in classic and common migraine. Cephalalgia 1987;7:87–92.
  16. Unge G, Malmgren R, Olsson P, et al. Effects of dietary protein-tryptophan restriction upon 5-HT uptake by platelets and clinical symptoms in migraine-like headache. Cephalalgia 1983;3:213–8.
  17. Kangasniemi P, Falck B, Langvik V-A, Hyyppa MT. Levotryptophan treatment in migraine. Headache 1978;18:161–6.
  18. Gasbarrini A, De Luca A, Fiore G, et al. Beneficial effects of Helicobacter pylori eradication on migraine. Hepatogastroenterology 1998;45:765–70.
  19. Gallai V, Sarchielli P, Coata G, et al. Serum and salivary magnesium levels in migraine. Results in a group of juvenile patients. Headache 1992;32:132–5.
  20. Baker B. New research approach helps clarify magnesium/migraine link. Family Pract News 1993;Aug 15:16.
  21. Barbiroli B, Lodi R, Cortelli P, et al. Low brain free magnesium in migraine and cluster headache: an interictal study by in vivo phosphorus magnetic resonance spectroscopy on 86 patients. Cephalalgia 1997;17:254.
  22. Mazzotta G, Sarchielli P, Alberti A, Gallai V. Intracellular Mg++ concentration and electromyographical ischemic test in juvenile headache. Cephalalgia 1999;19:802–9.
  23. Weaver K. Magnesium and migraine. Headache 1990;30:168 [letter].
  24. Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 1996;16:257–63.
  25. Facchinetti F, Sances G, Borella P, et al. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 1991;31:298–301.
  26. Pfaffenrath V, Wessely P, Meyer C, et al. Magnesium in the prophylaxis of migraine—a double-blind placebo-controlled study. Cephalalgia 1996;16:436–40.
  27. Mauskop A, Altura BT, Cracco RQ, Altura BM. Intravenous magnesium sulphate relieves migraine attacks in patients with low serum ionized magnesium levels: a pilot study. Clin Sci 1995;89:633–6.
  28. Schoenen J, Lenaerts M, Bastings E. High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study. Cephalalgia 1994;14:328–9.
  29. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 1998;50:466–70.
  30. Schoenen J, Jacquy, Lenaerts M. High-dose riboflavin as a novel prophylactic antimigraine therapy: results from a double-blind, randomized, placebo-controlled trial. Cephalalgia 1997;17:244 [abstract].
  31. van der Kuy PHM, Merkus FWHM, Lohman JJHM, ter Berg JWM, Hooymans PM. Hydroxocobalamin, a nitric oxide scavenger, in the prophylaxis of migraine: an open, pilot study. Cephalalgia 2002;22:513–9.
  32. Kimball RW, Friedman AP, Vallejo E. Effect of serotonin in migraine patients. Neurology 1960;10:107–11.
  33. Sicuteri F. The ingestion of serotonin precursors (L-5-hydroxytryptophan and L-tryptophan) improves migraine headache. Headache 1973;13:19–22.
  34. Titus F, Davalos A, Alom J, Codina A. 5-hydroxytryptophan versus methysergide in the prophylaxis of migraine. Eur Neurol 1986;25:327–9.
  35. Maissen CP, Ludin HP. Comparison of the effect of 5-hydroxytryptophan and propranolol in the interval treatment of migraine . Schweizerische Medizinische Wochenschrift /Journal Suisse de Medecine 1991;121:1585–90 [in German].
  36. De Benedittis G, Massei R. 5-HT precursors in migraine prophylaxis: A double-blind cross-over study with L-5-hydroxytryptophan versus placebo. Clin J Pain 1986;3:123–9.
  37. Mathew NT. 5-hydroxytryptophan in the prophylaxis of migraine. Headache 1978;18:111–3.
  38. Bono G, Criscuoli M, Martignoni E, et al. Serotonin precursors in migraine prophylaxis. Advances in Neurology 1982;33:357–63.
  39. De Giorgis G, Miletto R, Iannuccelli M, et al. Headache in association with sleep disorders in children: A psychodiagnostic evaluation and controlled clinical study ñ L-5-HTP versus placebo. Drugs Exptl Clin Res 1987;13:425–33.
  40. Santucci M, Cortelli P, Rossi PG, et al. L-5-Hydroxytryptophan versus placebo in childhood migraine prophylaxis: a double-blind crossover study. Cephalalgia 1986;6:155–7.
  41. McCarren T, Hitzemann R, Allen C, et al. Amelioration of severe migraine by fish oil (omega-3) fatty acids. Am J Clin Nutr 1985;41:874 [abstract].
  42. Glueck CJ, McCarren T, Hitzemann R, et al. Amelioration of severe migraine with omega-3 fatty acids: a double-blind placebo controlled clinical trial. Am J Clin Nutr 1986;43:710 [abstract].
  43. Thys-Jacobs S. Vitamin D and calcium in menstrual migraine. Headache 1994;34:544–6.
  44. Thys-Jacobs S. Alleviation of migraines with therapeutic vitamin D and calcium. Headache 1994;34:590–2.
  45. Rozen TD, Oshinsky ML, Gebeline CA,, et al. Open label trial of coenzyme Q10 as a migraine preventive. Cephalalgia 2002;22:137–41.
  46. Gatto G, Caleri D, Michelacci S, Sicuteri F. Analgesizing effect of a methyl donor (S-adenosylmethionine) in migraine: an open clinical trial. Int J Clin Pharmacol Res 1986;6:15–7.
  47. Claustrat B, Brun J, Geoffriau M, et al. Nocturnal plasma melatonin profile and melatonin kinetics during infusion in status migrainosus. Cephalalgia 1997;17:511–7 (discussion 487).
  48. Nagtegaal JE, Smits MG, Swart AC, et al. Melatonin-responsive headache in delayed sleep phase syndrome: preliminary observations. Headache 1998;38:303–7.
  49. Volger BK, Pittler MH, Ernst E. Feverfew as a preventive treatment for migraine: a systematic review. Cephalagia 1998;18:704–8.
  50. Murphy JJ, Hepinstall S, Mitchell JRA. Randomized double-blind placebo controlled trial of feverfew in migraine prevention. Lancet 1988;ii:189–92.
  51. Johnson ES, Kadam NP, Hylands DM, Hylands PJ. Efficacy of feverfew as prophylactic treatment of migraine. Br Med J 1985;291:569–73.
  52. Palevitch D, Earon G, Carasso R. Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: A double-blind placebo-controlled study. Phytother Res 1997;11:508–11.
  53. De Weerdt CJ, Bootsma HPR, Hendriks H. Herbal medicines in migraine prevention. Phytomed 1996;3:225–30.
  54. Awang DVC. Parthenolide: The demise of a facile theory of feverfew activity. J Herbs Spices Medicinal Plants 1998;5:95–8.
  55. Mustafa T, Srivastava KC. Ginger (Zingiber officinale) in migraine headache. J Ethnopharmacol 1990;29:267–73.
  56. Chung KF, McCusker M, Page CP, et al. Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man. Lancet 1987;i:248–51.
  57. Grossman W. Migraine prophylaxis with a phytophramceutical remedy: The results of a randomized, placebo-controlled, double-blind clinical study with Petadolex™. Der Freie Arzt 1996;May/June: 3.
  58. Levy RL. Intranasal capsaicin for acute abortive treatment of migraine without aura. Headache 1995;35:277 [letter].
  59. Baischer W. Acupuncture in migraine: long-term outcome and predicting factors. Headache 1995;35:472–4.
  60. Boivie J, Brattberg G. Are there long lasting effects on migraine headache after one series of acupuncture treatments? Am J Chin Med 1987;15:69–75.
  61. Loh L, Nathan PW, Schott GD, Zilkha KJ. Acupuncture versus medical treatment for migraine and muscle tension headaches. J Neurol Neurosurg Psychiatry 1984;47:333–7.
  62. Spoerel WE, Varkey M, Leung CY. Acupuncture in chronic pain. Am J Chin Med 1976;4:267–79.
  63. Vincent CA. A controlled trial of the treatment of migraine by acupuncture. Clin J Pain 1989;5:305–12.
  64. Lenhard L, Waite PME. Acupuncture in the prophylactic treatment of migraine headaches: pilot study. NZ Med J 1983;96:663–6.
  65. Vincent CA. A controlled trial of the treatment of migraine by acupuncture. Clin J Pain 1989;5:305–12.
  66. Baischer W. Acupuncture in migraine: long-term outcome and predicting factors. Headache 1995;35:472–4.
  67. Cheng AC. The treatment of headaches employing acupuncture. Am J Chin Med 1975;3:181–5.
  68. Shuyuan G, Donglan Z, Yanguang X. A comparative study on the treatment of migraine headache with combined distant and local acupuncture points versus conventional drug therapy. Am J Acupuncture 1999;27:27–30.
  69. Hesse J, Mogelvang B, Simonsen H. Acupuncture versus metoprolol in migraine prophylaxis: a randomized trial of trigger point inactivation. J Intern Med 1994;235:451–6.
  70. Ahmed HE, White PF, Craig WF, et al. Use of percutaneous electrical nerve stimulation (PENS) in the short-term management of headache. Headache 2000;40:311–5.
  71. Tuchin PJ. A case series of migraine changes following a manipulative therapy trial. Australasian Chiropractic and Osteopathy 1997;6(3):85–91.
  72. Vernon H, Steiman I, Hagino C. Cervicogenic dysfunction in muscle contraction headache and migraine: a descriptive study. J Manipulative Physiol Ther 1992;15:418–29.
  73. Kidd RF, Nelson R. Musculoskeletal dysfunction of the neck in migraine and tension headache. Headache 1993;33: 566–9.
  74. Wight JS. Migraine: a statistical analysis of chiropractic treatment. ACA J Chiropractic 1978;12S:63–7.
  75. Stodolny J, Chmielewski H. Manual therapy in the treatment of patients with cervical migraine. Man Med 1989;4:49–51.
  76. Tuchin PJ. A twelve month clinical trial of chiropractic spinal manipulative therapy for migraine. ACO 1999;8(2):61–5.
  77. Parker GB, Tupling H. Pryor D. A controlled trial of manipulation for migraine. Aust NZ J Med 1978;8:589–93.
  78. Parker GB, Tupling H, Pryor D. Why does migraine improve during a clinical trial? Further results from a trial of cervical manipulation for migraine. Aust NZ J Med 1980;10:192–8.
  79. Tuchin P, Pollard H, Bonello R. A randomized controlled trial of chiropractic spinal manipulative therapy for migraine. J Manipulative Physiol Ther 2000;23:91–5.
  80. Nelson CF, Bronfort G, Evans R, et al. The efficacy of spinal manipulation, amitripyline and the combination of both therapies for the prophylaxis of migraine headache. J Manipulative Physiol Ther 1998;21:511–8.